These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 29161006)

  • 1. ToP-DNJ, a Selective Inhibitor of Endoplasmic Reticulum α-Glucosidase II Exhibiting Antiflaviviral Activity.
    Kiappes JL; Hill ML; Alonzi DS; Miller JL; Iwaki R; Sayce AC; Caputo AT; Kato A; Zitzmann N
    ACS Chem Biol; 2018 Jan; 13(1):60-65. PubMed ID: 29161006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of endoplasmic reticulum glucosidases is required for in vitro and in vivo dengue antiviral activity by the iminosugar UV-4.
    Warfield KL; Plummer EM; Sayce AC; Alonzi DS; Tang W; Tyrrell BE; Hill ML; Caputo AT; Killingbeck SS; Beatty PR; Harris E; Iwaki R; Kinami K; Ide D; Kiappes JL; Kato A; Buck MD; King K; Eddy W; Khaliq M; Sampath A; Treston AM; Dwek RA; Enterlein SG; Miller JL; Zitzmann N; Ramstedt U; Shresta S
    Antiviral Res; 2016 May; 129():93-98. PubMed ID: 26946111
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure-Based Design of Potent Iminosugar Inhibitors of Endoplasmic Reticulum α-Glucosidase I with Anti-SARS-CoV-2 Activity.
    Karade SS; Franco EJ; Rojas AC; Hanrahan KC; Kolesnikov A; Yu W; MacKerell AD; Hill DC; Weber DJ; Brown AN; Treston AM; Mariuzza RA
    J Med Chem; 2023 Feb; 66(4):2744-2760. PubMed ID: 36762932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Strategy for Designing Selective Lysosomal Acid α-Glucosidase Inhibitors: Binding Orientation and Influence on Selectivity.
    Kato A; Nakagome I; Hata M; Nash RJ; Fleet GWJ; Natori Y; Yoshimura Y; Adachi I; Hirono S
    Molecules; 2020 Jun; 25(12):. PubMed ID: 32575625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N-Substituted Valiolamine Derivatives as Potent Inhibitors of Endoplasmic Reticulum α-Glucosidases I and II with Antiviral Activity.
    Karade SS; Hill ML; Kiappes JL; Manne R; Aakula B; Zitzmann N; Warfield KL; Treston AM; Mariuzza RA
    J Med Chem; 2021 Dec; 64(24):18010-18024. PubMed ID: 34870992
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting Endoplasmic Reticulum α-Glucosidase I with a Single-Dose Iminosugar Treatment Protects against Lethal Influenza and Dengue Virus Infections.
    Warfield KL; Alonzi DS; Hill JC; Caputo AT; Roversi P; Kiappes JL; Sheets N; Duchars M; Dwek RA; Biggins J; Barnard D; Shresta S; Treston AM; Zitzmann N
    J Med Chem; 2020 Apr; 63(8):4205-4214. PubMed ID: 32227946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of α-glucosidase activity by N-deoxynojirimycin analogs in several insect phloem sap feeders.
    Ya'kobovitz MK; Butters TD; Cohen E
    Insect Sci; 2016 Feb; 23(1):59-67. PubMed ID: 25900765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and glycosidase inhibition of conformationally locked DNJ and DMJ derivatives exploiting a 2-oxo-C-allyl iminosugar.
    Foucart Q; Shimadate Y; Marrot J; Kato A; Désiré J; Blériot Y
    Org Biomol Chem; 2019 Aug; 17(30):7204-7214. PubMed ID: 31317164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiviral effects of deoxynojirimycin (DNJ)-based iminosugars in dengue virus-infected primary dendritic cells.
    Perera N; Brun J; Alonzi DS; Tyrrell BE; Miller JL; Zitzmann N
    Antiviral Res; 2022 Mar; 199():105269. PubMed ID: 35227758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterizing the selectivity of ER α-glucosidase inhibitors.
    O'Keefe S; Roebuck QP; Nakagome I; Hirono S; Kato A; Nash R; High S
    Glycobiology; 2019 Jul; 29(7):530-542. PubMed ID: 30976784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiviral effects of an iminosugar derivative on flavivirus infections.
    Wu SF; Lee CJ; Liao CL; Dwek RA; Zitzmann N; Lin YL
    J Virol; 2002 Apr; 76(8):3596-604. PubMed ID: 11907199
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiviral therapies targeting host ER alpha-glucosidases: current status and future directions.
    Chang J; Block TM; Guo JT
    Antiviral Res; 2013 Sep; 99(3):251-60. PubMed ID: 23816430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Iminosugars Inhibit Dengue Virus Production via Inhibition of ER Alpha-Glucosidases--Not Glycolipid Processing Enzymes.
    Sayce AC; Alonzi DS; Killingbeck SS; Tyrrell BE; Hill ML; Caputo AT; Iwaki R; Kinami K; Ide D; Kiappes JL; Beatty PR; Kato A; Harris E; Dwek RA; Miller JL; Zitzmann N
    PLoS Negl Trop Dis; 2016 Mar; 10(3):e0004524. PubMed ID: 26974655
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kinetic analysis of inhibition of α-glucosidase by leaf powder from
    Qiao Y; Nakayama J; Ikeuchi T; Ito M; Kimura T; Kojima K; Takita T; Yasukawa K
    Biosci Biotechnol Biochem; 2020 Oct; 84(10):2149-2156. PubMed ID: 32660357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and characterization of novel, conjugated, fluorescent DNJ derivatives for α-glucosidase recognition.
    Hatano A; Kanno Y; Kondo Y; Sunaga Y; Umezawa H; Okada M; Yamada H; Iwaki R; Kato A; Fukui K
    Bioorg Med Chem; 2017 Jan; 25(2):773-778. PubMed ID: 27956035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Imino sugars inhibit the formation and secretion of bovine viral diarrhea virus, a pestivirus model of hepatitis C virus: implications for the development of broad spectrum anti-hepatitis virus agents.
    Zitzmann N; Mehta AS; Carrouée S; Butters TD; Platt FM; McCauley J; Blumberg BS; Dwek RA; Block TM
    Proc Natl Acad Sci U S A; 1999 Oct; 96(21):11878-82. PubMed ID: 10518544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structures of mammalian ER α-glucosidase II capture the binding modes of broad-spectrum iminosugar antivirals.
    Caputo AT; Alonzi DS; Marti L; Reca IB; Kiappes JL; Struwe WB; Cross A; Basu S; Lowe ED; Darlot B; Santino A; Roversi P; Zitzmann N
    Proc Natl Acad Sci U S A; 2016 Aug; 113(32):E4630-8. PubMed ID: 27462106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dietary 5,6,7-Trihydroxy-flavonoid Aglycones and 1-Deoxynojirimycin Synergistically Inhibit the Recombinant Maltase-Glucoamylase Subunit of α-Glucosidase and Lower Postprandial Blood Glucose.
    Dong YS; Yu N; Li X; Zhang B; Xing Y; Zhuang C; Xiu ZL
    J Agric Food Chem; 2020 Aug; 68(33):8774-8787. PubMed ID: 32806121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, synthesis, and biological evaluation of N-alkylated deoxynojirimycin (DNJ) derivatives for the treatment of dengue virus infection.
    Yu W; Gill T; Wang L; Du Y; Ye H; Qu X; Guo JT; Cuconati A; Zhao K; Block TM; Xu X; Chang J
    J Med Chem; 2012 Jul; 55(13):6061-75. PubMed ID: 22712544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel imino sugar α-glucosidase inhibitors as antiviral compounds.
    Howe JD; Smith N; Lee MJ; Ardes-Guisot N; Vauzeilles B; Désiré J; Baron A; Blériot Y; Sollogoub M; Alonzi DS; Butters TD
    Bioorg Med Chem; 2013 Aug; 21(16):4831-8. PubMed ID: 23582447
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.